dostęp otwarty

Tom 3, Nr 4 (2017)
Prace kazuistyczne
Opublikowany online: 2018-03-01
Pobierz cytowanie

Diagnosis of dermatophytoses still problematic for general practitioners — 10 case studies and review of literature

Nicole Machnikowski, Wioletta Barańska-Rybak, Aleksandra Wilkowska, Roman Nowicki
Forum Dermatologicum 2017;3(4):157-165.

dostęp otwarty

Tom 3, Nr 4 (2017)
Prace kazuistyczne
Opublikowany online: 2018-03-01

Streszczenie

Dermatophytoses, also referred to as tinea or ringworm, is a fungal infection of keratinized tissues (skin, hair, nails) caused by Trichophyton, Microsporum and Epidermophyton dermatophytes. It presents clinically as an erythematous, scaly, pruritic rash with a well-defined border. Diagnostic errors are not uncommon with this condition. It can have a close resemblance to lesions of another etiology (e.g. psoriasis, discoid eczema) or present atypically due to the prior use of topical steroid preparations (e.g. tinea incognito). A cohort of 10 cases with varying initial misdiagnoses of dermatophyte infection were analysed based on on their cutaneous presentations, clinical course, and treatments in order to give guidance for general practitioners.

Streszczenie

Dermatophytoses, also referred to as tinea or ringworm, is a fungal infection of keratinized tissues (skin, hair, nails) caused by Trichophyton, Microsporum and Epidermophyton dermatophytes. It presents clinically as an erythematous, scaly, pruritic rash with a well-defined border. Diagnostic errors are not uncommon with this condition. It can have a close resemblance to lesions of another etiology (e.g. psoriasis, discoid eczema) or present atypically due to the prior use of topical steroid preparations (e.g. tinea incognito). A cohort of 10 cases with varying initial misdiagnoses of dermatophyte infection were analysed based on on their cutaneous presentations, clinical course, and treatments in order to give guidance for general practitioners.

Pobierz cytowanie

Słowa kluczowe

tinea, dermatophyte, corticosteroids, antifungal treatment, tinea incognito

Informacje o artykule
Tytuł

Diagnosis of dermatophytoses still problematic for general practitioners — 10 case studies and review of literature

Czasopismo

Forum Dermatologicum

Numer

Tom 3, Nr 4 (2017)

Strony

157-165

Data publikacji on-line

2018-03-01

Rekord bibliograficzny

Forum Dermatologicum 2017;3(4):157-165.

Słowa kluczowe

tinea
dermatophyte
corticosteroids
antifungal treatment
tinea incognito

Autorzy

Nicole Machnikowski
Wioletta Barańska-Rybak
Aleksandra Wilkowska
Roman Nowicki

Referencje (35)
  1. Wolff K, Saavedra AP, Fitzpatrick TB. Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology 7th ed. McGraw-Hill Medical, New York. ; 2013: 591–628.
  2. Hube B, Hay R, Brasch J, et al. Dermatomycoses and inflammation: The adaptive balance between growth, damage, and survival. J Mycol Med. 2015; 25(1): e44–e58.
  3. Fisher DA. Adverse effects of topical corticosteroid use. West J Med. 1995; 162(2): 123–126.
  4. Rosenthal JR. Fungal infections of the skin. In: Gorbach SL, Bartlett JG, Blacklow NR eds. Infectious Diseases, 3rd edn. Lippincott Williams and Wilkins, London. ; 2004: 1162–1180.
  5. Habif P. Clinical Dermatology-Sixth edition. Elsevier Health Sciences. ; 2015: 86–503.
  6. Elghblawi E. Extensive ‘Tinea Incognito’ Due to Topical Steroid: A Case Report. JMED Research. 2013: 1–3.
  7. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008; 51 Suppl 4: 2–15.
  8. Panackal AA, Halpern EF, Watson AJ. Cutaneous fungal infections in the United States: Analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995-2004. Int J Dermatol. 2009; 48(7): 704–712.
  9. Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol. 2010; 28(2): 197–201.
  10. Watanabe S. Dermatomycosis--classification, etiology, pathogenesis, and treatment. Nihon Rinsho. 2008 Dec; 66(12): 2285–9.
  11. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008; 166(5-6): 335–352.
  12. Jacobs JA, Kolbach DN, Vermeulen AH, et al. Tinea incognito due to Trichophytom rubrum after local steroid therapy. Clin Infect Dis. 2001; 33(12): E142–E144.
  13. Segal D, Wells MM, Rahalkar A, et al. A case of tinea incognito. Dermatol Online J. 2013; 19(5): 18175.
  14. Proudfoot L, Morris-Jones R. Kerion Celsi. New England Journal of Medicine. 2012; 366(12): 1142–1142.
  15. William D, Berger T, Elston D. Andrew’s Diseases of the Skin: Clinical Dermatology. Elsevier Health Sciences. 2016; 290.
  16. ‪Rycroft R‬, Robertson S. Wakelin‬ S. Dermatology: A Colour Handbook, Second Edition‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬. Manson Publishing Ltd, London. ; 2010: 222–223.
  17. Ive FA, Marks R. Tinea incognito. Br Med J. 1968; 3(5611): 149–152.
  18. Krajewska-Kulak E, Niczyporuk W, Lukaszuk C, et al. Difficulties in diagnosing and treating tinea in adults at the Department of Dermatology in Bialystok (Poland). Dermatol Nurs. 2003; 15(6): 527–30, 534.
  19. Gorani A, Schiera A, Oriani A. Case report. Rosacea-like Tinea incognito. Mycoses. 2002; 45(3-4): 135–137.
  20. Berk T, Scheinfeld N. Seborrheic dermatitis. 2010; 35(6): 348–352.
  21. Arenas R, Moreno-Coutiño G, Vera L, et al. Tinea incognito. Clin Dermatol. 2010; 28(2): 137–139.
  22. Crawford KM, Bostrom P, Russ B, et al. Pimecrolimus-induced tinea incognito. Skinmed. 2004; 3(6): 352–353.
  23. Meymandi S, Wiseman MC, Crawford RI. Tinea faciei mimicking cutaneous lupus erythematosus: a histopathologic case report. J Am Acad Dermatol. 2003; 48(2 Suppl): S7–S8.
  24. Feder HM. Tinea incognito misdiagnosed as erythema migrans. N Engl J Med. 2000; 343(1): 69.
  25. Rallis E, Koumantaki-Mathioudaki E. Pimecrolimus induced tinea incognito masquerading as intertriginous psoriasis. Mycoses. 2008; 51(1): 71–73.
  26. Lee JI, Jung HY, Lee YB, et al. A case of localized scleroderma mimicking tinea cruris. Cutis. 2013; 92(3): E5–E6.
  27. Guenova E, Hoetzenecker W, Schaller M, et al. Tinea incognito hidden under apparently treatment-resistant pemphigus foliaceus. Acta Derm Venereol. 2008; 88(3): 276–277.
  28. ; 1(67): 101–109.
  29. Garg J, Tilak R, Garg A, et al. Rapid detection of dermatophytes from skin and hair. BMC Res Notes. 2009; 2: 60.
  30. Rathi SK, D'Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian J Dermatol. 2012; 57(4): 251–259.
  31. Kastelan M, Massari LP, Brajac I. Tinea incognito due to Trichophyton rubrum--a case report. Coll Antropol. 2009; 33(2): 665–667.
  32. Şatana D. A case of Tinea incognito diagnosed coincidentally. Journal of Microbiology and Infectious Diseases. 2011; 01(02): 84–86.
  33. Siddaiah N, Erickson Q, Miller G, et al. Tacrolimus-induced tinea incognito. Cutis. 2004; 73(4): 237–238.
  34. Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008; 166(5-6): 353–367.
  35. Medicines and Healthcare products Regulatory Agency. Oral ketoconazole: do not prescribe or use for fungal infections—risk of liver injury outweighs benefits. 2013.

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl